These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31182139)

  • 1. Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
    Aliyu MH; Wudil UJ; Ingles DJ; Shepherd BE; Gong W; Musa BM; Muhammad H; Sani MU; Abdu A; Nalado AM; Atanda A; Ahonkhai AA; Ikizler TA; Winkler CA; Kopp JB; Kimmel PL; Wester CW
    Trials; 2019 Jun; 20(1):341. PubMed ID: 31182139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design.
    Wester CW; Shepherd BE; Wudil UJ; Musa BM; Ingles DJ; Prigmore HL; Dankishiya FS; Ahonkhai AA; Grema BA; Budge PJ; Takakura A; Olabisi OA; Winkler CA; Kopp JB; Bonventre JV; Wyatt CM; Aliyu MH
    BMC Infect Dis; 2022 Jul; 22(1):591. PubMed ID: 35787257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria.
    Wudil UJ; Aliyu MH; Prigmore HL; Ingles DJ; Ahonkhai AA; Musa BM; Muhammad H; Sani MU; Nalado AM; Abdu A; Abdussalam K; Shepherd BE; Dankishiya FS; Burgner AM; Ikizler TA; Wyatt CM; Kopp JB; Kimmel PL; Winkler CA; Wester CW
    Kidney Int; 2021 Jul; 100(1):146-154. PubMed ID: 33901548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
    Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
    Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1-associated kidney disease in northern Nigerians with treated HIV infection.
    Olabisi OA; Freedman BI
    Kidney Int; 2021 Jul; 100(1):19-21. PubMed ID: 34154709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
    Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
    Pelchen-Matthews A; Mocroft A; Ryom L; Ross MJ; Sharma S; Coca S; Achhra A; Cornell E; Tracy R; Phillips A; Alonso MM; Toulomi G; Agan BK; Medland N; Wyatt CM;
    Kidney Int; 2024 Jul; 106(1):136-144. PubMed ID: 38697479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
    Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
    Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
    Hassan MO; Duarte R; Mabayoje VO; Dickens C; Lasisi AO; Naicker S
    BMC Nephrol; 2020 Oct; 21(1):436. PubMed ID: 33066744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein L1 and kidney transplantation.
    Tedla FM; Yap E
    Curr Opin Organ Transplant; 2019 Feb; 24(1):97-102. PubMed ID: 30507707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
    Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
    Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A focus on the association of Apol1 with kidney disease in children.
    Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
    Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell trait, APOL1 risk allele status and chronic kidney disease among ART-experienced adults living with HIV in northern Nigeria.
    Abdulhamid A; Shepherd BE; Wudil UJ; Van Wyk C; Dankishiya FS; Hussaini N; Wester CW; Aliyu MH
    Int J STD AIDS; 2024 Jun; ():9564624241262397. PubMed ID: 38915133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Injury in APOL1-associated Kidney Disease.
    Ma L; Divers J; Freedman BI
    Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
    Waziri B; Raji YE; Ekrikpo UE; Naicker S
    J Nephrol; 2023 May; 36(4):1119-1134. PubMed ID: 36510118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
    Keyzer CA; de Jong MA; Fenna van Breda G; Vervloet MG; Laverman GD; Hemmelder M; Janssen WM; Lambers Heerspink HJ; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2016 Jul; 31(7):1081-7. PubMed ID: 25744274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.
    Gutiérrez OM; Limou S; Lin F; Peralta CA; Kramer HJ; Carr JJ; Bibbins-Domingo K; Winkler CA; Lewis CE; Kopp JB
    Kidney Int; 2018 Mar; 93(3):727-732. PubMed ID: 29042080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host factors predisposing to kidney disease in people with HIV.
    Hung RKY; Winkler CA; Post FA
    Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.